NO20042133L - Vaskulaer stent eller transplantasjonsbelagt eller impregnert protein, tyrosinkinaseinhibitoerer og fremgangsmater for anvendelse av disse - Google Patents

Vaskulaer stent eller transplantasjonsbelagt eller impregnert protein, tyrosinkinaseinhibitoerer og fremgangsmater for anvendelse av disse

Info

Publication number
NO20042133L
NO20042133L NO20042133A NO20042133A NO20042133L NO 20042133 L NO20042133 L NO 20042133L NO 20042133 A NO20042133 A NO 20042133A NO 20042133 A NO20042133 A NO 20042133A NO 20042133 L NO20042133 L NO 20042133L
Authority
NO
Norway
Prior art keywords
graft
coated
methods
tyrosine kinase
kinase inhibitors
Prior art date
Application number
NO20042133A
Other languages
English (en)
Norwegian (no)
Inventor
Matthew R Wolff
Scott William Stoker
Michael Orrin Griffin
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of NO20042133L publication Critical patent/NO20042133L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A61F2/07—Stent-grafts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20042133A 2001-10-25 2004-05-24 Vaskulaer stent eller transplantasjonsbelagt eller impregnert protein, tyrosinkinaseinhibitoerer og fremgangsmater for anvendelse av disse NO20042133L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34373201P 2001-10-25 2001-10-25
PCT/US2002/034344 WO2003034938A2 (en) 2001-10-25 2002-10-25 Vascular stent or graft coated or impregnated with protein tyrosine kinase inhibitors and method of using same

Publications (1)

Publication Number Publication Date
NO20042133L true NO20042133L (no) 2004-07-09

Family

ID=23347387

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042133A NO20042133L (no) 2001-10-25 2004-05-24 Vaskulaer stent eller transplantasjonsbelagt eller impregnert protein, tyrosinkinaseinhibitoerer og fremgangsmater for anvendelse av disse

Country Status (18)

Country Link
US (1) US20040044405A1 (es)
EP (1) EP1441749A4 (es)
JP (1) JP2006519623A (es)
KR (1) KR20040051618A (es)
CN (1) CN1635858A (es)
BR (1) BR0213497A (es)
CA (1) CA2464093A1 (es)
CO (1) CO5580792A2 (es)
EC (1) ECSP045085A (es)
HU (1) HUP0402036A3 (es)
IL (1) IL161583A0 (es)
MX (1) MXPA04003906A (es)
NO (1) NO20042133L (es)
NZ (1) NZ532593A (es)
PL (1) PL374315A1 (es)
RU (1) RU2004116068A (es)
WO (1) WO2003034938A2 (es)
ZA (1) ZA200403184B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1509219A1 (en) * 2002-05-13 2005-03-02 Beth Israel Deaconess Medical Center Methods and compositions for the treatment of graft failure
AU2003247634B2 (en) 2002-06-26 2008-07-17 Cook Incorporated Stent-graft fastening
US20050214343A1 (en) * 2002-07-18 2005-09-29 Patrice Tremble Medical devices comprising a protein-tyrosine kinase inhibitor to inhibit restonosis
WO2004108130A1 (en) * 2003-06-03 2004-12-16 Beth Israel Deaconess Medical Center Methods and compounds for the treatment of vascular stenosis
WO2005095641A1 (en) * 2004-03-03 2005-10-13 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with mitogen-activated protein kinase kinase kinase 11 (map3k11)
US8399609B2 (en) 2004-03-05 2013-03-19 Regenerx Biopharmaceuticals, Inc. Treating or preventing extracellular matrix build-up
MX2007001155A (es) * 2004-07-29 2007-08-14 Creabilis Therapeutics Spa Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1.
US20070065477A1 (en) * 2005-09-12 2007-03-22 Conor Medsystems, Inc. Composition, system, and method for modulating release kinetics in implantable drug delivery devices by modifying drug solubility
US20070196428A1 (en) * 2006-02-17 2007-08-23 Thierry Glauser Nitric oxide generating medical devices
JP5110559B2 (ja) * 2006-11-24 2012-12-26 学校法人近畿大学 被覆ステント
US8217172B2 (en) 2007-12-07 2012-07-10 Vertex Pharmaceuticals Incorporated Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1H-benzo[d]imidazol-2-yl)urea
EP3159033B1 (en) * 2008-05-01 2019-02-27 Bayer Intellectual Property GmbH Catheter balloon drug adherence techniques and methods
WO2010093889A2 (en) 2009-02-13 2010-08-19 Vertex Pharmaceuticals Incorporated Solid forms of 2-(2, 4-difluorophenyl)-6-(1-(2,6-difluorophenyl)ureido)nicotinamide
US9265633B2 (en) 2009-05-20 2016-02-23 480 Biomedical, Inc. Drug-eluting medical implants
US9309347B2 (en) 2009-05-20 2016-04-12 Biomedical, Inc. Bioresorbable thermoset polyester/urethane elastomers
US8992601B2 (en) 2009-05-20 2015-03-31 480 Biomedical, Inc. Medical implants
CA3186201A1 (en) * 2009-05-20 2010-11-25 Lyra Therapeutics, Inc. Self-expandable medical device comprising polymeric strands and coatings thereon
US20110319987A1 (en) 2009-05-20 2011-12-29 Arsenal Medical Medical implant
US8888840B2 (en) * 2009-05-20 2014-11-18 Boston Scientific Scimed, Inc. Drug eluting medical implant
US8372133B2 (en) * 2009-10-05 2013-02-12 480 Biomedical, Inc. Polymeric implant delivery system
AU2012205419B2 (en) 2011-01-14 2016-12-15 Spero Therapeutics, Inc. Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl) pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-yl]urea
EP2663557B1 (en) 2011-01-14 2015-05-27 Vertex Pharmaceuticals Incorporated Pyrimidine gyrase and topoisomerase iv inhibitors
US9187953B2 (en) 2011-03-23 2015-11-17 Rytec Corporation Side column configuration for overhead roll-up door assemblies
JP5977344B2 (ja) 2011-06-20 2016-08-24 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ ジャイレースおよびトポイソメラーゼ阻害剤のリン酸エステル
WO2013003157A1 (en) 2011-06-28 2013-01-03 Yale University Cell-free tissued engineered vascular grafts
US9018216B2 (en) 2012-07-18 2015-04-28 Vertex Pharmaceuticals Incorporated Solid forms of (R)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1H-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof
PT3424920T (pt) 2013-10-17 2020-07-07 Vertex Pharma Co-cristais de (s)-n-metil-8-(1-((2'-metil-[4,5'-bipirimidin]-6-il)amino)propan-2-il)quinolina-4-carboxamida e derivados deuterados dos mesmos como inibidores de adn-pk
CN108601863A (zh) 2015-12-11 2018-09-28 国家儿童医院研究所 用于优化的患者特异性组织工程化血管移植物的***和方法
US11628239B2 (en) 2016-11-04 2023-04-18 University Of Delaware Method for protecting skeletonized blood vessels

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824436A (en) * 1985-04-09 1989-04-25 Harvey Wolinsky Method for the prevention of restenosis
US5171217A (en) * 1991-02-28 1992-12-15 Indiana University Foundation Method for delivery of smooth muscle cell inhibitors
US5521184A (en) * 1992-04-03 1996-05-28 Ciba-Geigy Corporation Pyrimidine derivatives and processes for the preparation thereof
US6306421B1 (en) * 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5354774A (en) * 1992-12-24 1994-10-11 Yale University Inhibition of smooth muscle cell proliferation by 8-methoxypsoralen photoactivated by visible light
US5279565A (en) * 1993-02-03 1994-01-18 Localmed, Inc. Intravascular treatment apparatus and method
US5788687A (en) * 1994-02-01 1998-08-04 Caphco, Inc Compositions and devices for controlled release of active ingredients
US5788979A (en) * 1994-07-22 1998-08-04 Inflow Dynamics Inc. Biodegradable coating with inhibitory properties for application to biocompatible materials
US6306165B1 (en) * 1996-09-13 2001-10-23 Meadox Medicals ePTFE small caliber vascular grafts with significant patency enhancement via a surface coating which contains covalently bonded heparin
US6245760B1 (en) * 1997-05-28 2001-06-12 Aventis Pharmaceuticals Products, Inc Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
CO4940418A1 (es) * 1997-07-18 2000-07-24 Novartis Ag Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
US6281225B1 (en) * 1998-06-11 2001-08-28 Cerus Corporation Inhibiting proliferation of arterial smooth muscle cells
CN1429222A (zh) * 2000-02-17 2003-07-09 安姆根有限公司 激酶抑制剂
US20020156023A1 (en) * 2000-12-06 2002-10-24 Tularik Inc. Lometrexol combination therapy
US6872715B2 (en) * 2001-08-06 2005-03-29 Kosan Biosciences, Inc. Benzoquinone ansamycins

Also Published As

Publication number Publication date
WO2003034938A3 (en) 2003-11-13
MXPA04003906A (es) 2005-02-17
BR0213497A (pt) 2006-05-23
HUP0402036A2 (hu) 2005-02-28
CO5580792A2 (es) 2005-11-30
CA2464093A1 (en) 2003-05-01
HUP0402036A3 (en) 2008-04-28
JP2006519623A (ja) 2006-08-31
IL161583A0 (en) 2004-09-27
EP1441749A4 (en) 2010-05-19
CN1635858A (zh) 2005-07-06
US20040044405A1 (en) 2004-03-04
PL374315A1 (en) 2005-10-03
WO2003034938A2 (en) 2003-05-01
EP1441749A2 (en) 2004-08-04
KR20040051618A (ko) 2004-06-18
NZ532593A (en) 2007-11-30
RU2004116068A (ru) 2005-03-20
ECSP045085A (es) 2004-07-23
ZA200403184B (en) 2005-05-12

Similar Documents

Publication Publication Date Title
NO20042133L (no) Vaskulaer stent eller transplantasjonsbelagt eller impregnert protein, tyrosinkinaseinhibitoerer og fremgangsmater for anvendelse av disse
ID30460A (id) Inhibitor-inhibitor protein siklik tirosin kinase
CY2014034I1 (el) Υποκατεστημενες 3-κυανοκινολινες ως αναστολεις κινασων πρωτεϊνης τυροσινης
NO20000487L (no) Substituerte quinazolinderivater og anvendelse derav som tyrosin-kinase-inhibitorer
NO20012583L (no) Kinoliner og kinoksalinforbindelser som PDGF-R- og/eller LCK- tyrosinkinaseinhibitorer
ZA200309738B (en) Inhibitors of macrophage migration inhibitory factor and methods for identifying the same.
AU2003228809A8 (en) Kinase anchor protein muteins, peptides thereof, and related methods
NO20021820L (no) Tyrosinkinaseinhibitorer
NO20053356D0 (no) Aminindazolderivater og anvendelse derav som kinaseinhibitorer.
NO20033548D0 (no) Modifiserte proteiner, designer toksiner og fremgangsmåter for fremstillingav disse
DK0797575T3 (da) Imidazolderivater som proteinkinase-inhibitorer, især EGF-R-tyrosinkinase
NO20035728D0 (no) Pyrrolopyrimidiner som proteinkinaseinhibitorer
NO20015062L (no) Substituerte 3-cyano-[1.7],[1.5]og[1.8]-naftyridin- inhibitorer for tyrosin-kinaser
NO20030579L (no) Vaskulaere grafter og fremgangsmater til implantering derav
NO20040249L (no) Blodgruppeantigenfusjonspolypeptider og fremgangsmater for deres anvendelse
DK0906268T3 (da) Alkoxyaminosubstituerede fluorenoner og deres anvendelse som proteinkinase C-inhibitorer
NO20040932L (no) Egnet stigerorsstrekkapparat, metode og system
NO20024105D0 (no) Memnopeptider, fremgangsmåte for deres fremstilling og anvendelse av disse
DK1341758T3 (da) Coniosetin og derivater af denne, fremgangsmåde til fremstilling og anvendelse af samme
IS7624A (is) Aðferð við losun íláts, og notkun þeirrar aðferðar
DK1389100T3 (da) Hidtil ukendte fremgangsmåder til behandling og forebyggelse af smerte under anvendelse af stressaktiverede proteinkinaseinhibitorer
DK1372670T3 (da) Caloporosid-derivater, fremgangsmåde til fremstillingen af disse og deres anvendelse
IL145329A0 (en) Protein tyrosine kinase inhibitors
AU2003256538A8 (en) Protein kinase c modulators, and methods of use thereof
ITRM20010433A0 (it) Metodo di analisi di un elettrocardiogramma e relativo apparato.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application